Emma A. Durand – Chief Executive Officer & Chief Technology Officer
As Chief Executive Officer & Chief Technology Officer, Ms. Durand is responsible for managing technology development for rapid product introduction, vendor qualification, design engineering and protection of intellectual property. She has over forty US and international patents, covering diverse areas of mechanical, electrical and chemical engineering, virtually all of which been employed in the development of successful commercial products.

Prior to founding the Company, Ms. Durand was Executive Vice President and Chief Technology Officer of American Biophysics Corp.; a co-founder and Chief Technology Officer of EvaluTech, LLC; the sole distributor of technology transfer for the Naval Underwater Systems Lab in Newport, RI. She also founded Sublimation Systems, Inc. the pioneer of four color printing of dyes; Key-Tech Inc., the pioneer of engineered plastic decoration and assembly; and Poly-Flex Circuit Inc., the pioneer in flexible circuit boards. Ms. Durand attended the Massachusetts Institute of Technology majoring in Mechanical Engineering.

Shawna Gvazdauskas - Chief Commercial Officer

As Chief Commercial Officer, Ms. Gvazdauskas is responsible for all commercial activities leading to the development of strategy and execution of business development and commercialization efforts for Isis technology.

Prior to joining Isis, Ms. Gvazdauskas was Senior Vice President of Sales & Marketing at Insulet Corporation where she was responsible for leading the commercial effort for the OmniPod® Insulin Management System. In addition to having built the Insulet sales force, she oversaw marketing, public relations, customer support and reimbursement.

Ms. Gvazdauskas also held positions in Sales at TheraSense® Inc. (acquired by Abbott Diabetes Care) and Johnson & Johnson/Ortho Neutrogena® .  Ms. Gvazdauskas began her career at Syntex Laboratories where she sold prescription drugs for the specialty markets of orthopedics, rheumatology, cardiology and primary care. Ms. Gvazdauskas earned a Bachelor of Science degree in Biology from Worcester State College.

Michael Jordan – Director of Product Development
Mr. Jordan is responsible for managing the product development process, vendor outsourcing and customer requirements. He has over 18 years of product development, manufacturing and sales experience relating to polymer thick film technology.

Prior to joining Isis Biopolymer, Mr. Jordan was the Product Development Manager for Parlex USA, a polymer thick film circuit and assembly supplier to the medical, appliance and telecom markets. He also held positions as an Application Engineer and Business Development Manager at Parlex (formally Poly-Flex Circuit Inc.). He attended Rhode Island College for Industrial Technology and is also a Six Sigma black belt from Worcester Polytechnic Institute.

Ang-Ling Chu, PhD – Vice President of Polymer Research
Dr. Chu has extensive experience in the product design and laboratory expertise of polymer development, specifically in analyzing and improving manufacturing processes, long-term testing and quality control of polymers and actual devices.

Dr. Chu previously held the position of Vice President of Research at Poly-Flex Circuits, Inc. where he was responsible for the creation of the R&D division, which also included managing projects, designing R&D procedures and QC tests, as well as improving the production efficiency in flexible circuit printing. Dr. Chu also held positions at Micron Technology, Inc. as a Senior Engineer responsible for the development of photo-definable micro tooling for advanced silicon insert technology, and more recently at Ciba Specialty Chemicals as a Technical Sales Manager for Optoelectronic Materials. He received a PhD in Chemistry from Rensselaer Polytechnic Institute, Troy, New York.

Miaoyong Cao, PhD – Director of Polymer Research
Dr. Cao is responsible for research and development of component materials for Isis Biopolymer’s proprietary transdermal drug delivery systems. He has over 30 years of experience in research and product development in polymer and material science as well as engineering. His contributions have been numerous to industries related to film electronic circuits as well as advanced environmental protection and medical devices.

Prior to join Isis Biopolymer Dr. Cao was Director of Research and Development at American Biophysics Corp. His work experience also includes Research and Product Development at Poly-flex Circuits. He also held positions at Rensselaer Polytechnic Institute, Chemistry and Material Science & Engineering Departments, Troy. NY. He is listed as co-inventor in 14 US and international patents and has authored 40 scientific papers and two books on polymer physics. He graduated from University of Science and Technology of China and received his PhD at Rensselaer Polytechnic Institute, Chemistry Department.

Bruce Becker, MD, MPH – Director of Clinical Research
Dr. Becker is responsible for overseeing the strategic direction, management and implementation of the clinical studies conducted by Isis Biopolymer, as well as the development of new and effective research collaborations with scientists and clinicians, hospitals, academic institutions, and pharmaceutical companies.

Dr. Becker is Professor of Emergency Medicine and Community Health at the Warren Alpert School of Medicine at Brown University. He has been on Brown’s faculty for more than 23 years. He continues to practice clinically as an attending physician in the Emergency Departments at Rhode Island Hospital and Hasbro Children’s Hospital. Dr. Becker received his undergraduate and medical degrees from Brown University School of Medicine. He conducted his graduate studies at Harvard University and received his Masters in Public Health in Health Policy and Management in Developing Nations. Dr. Becker has published more than 60 articles in peer-reviewed journals and participated in more than 25 externally funded research projects focusing on medical device development and public health issues.